176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.03%
Negative revenue growth while INTC stands at 101.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-70.57%
Negative gross profit growth while INTC is at 100.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
-218.87%
Negative EBIT growth while INTC is at 94.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-218.87%
Negative operating income growth while INTC is at 94.64%. Joel Greenblatt would press for urgent turnaround measures.
-202.45%
Negative net income growth while INTC stands at 93.48%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-203.33%
Negative EPS growth while INTC is at 96.55%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-206.90%
Negative diluted EPS growth while INTC is at 98.21%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.98%
Slight or no buybacks while INTC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-3.09%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
736.35%
Positive OCF growth while INTC is negative. John Neff would see this as a clear operational advantage vs. the competitor.
85.32%
FCF growth above 1.5x INTC's 15.27%. David Dodd would verify if the firm’s strategic investments yield superior returns.
544.50%
10Y revenue/share CAGR 1.25-1.5x INTC's 411.10%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
24.88%
5Y revenue/share CAGR under 50% of INTC's 248.67%. Michael Burry would suspect a significant competitive gap or product weakness.
-17.12%
Negative 3Y CAGR while INTC stands at 189.69%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
93.19%
10Y OCF/share CAGR at 50-75% of INTC's 134.42%. Martin Whitman might fear a structural deficiency in operational efficiency.
-35.81%
Negative 5Y OCF/share CAGR while INTC is at 179.70%. Joel Greenblatt would question the firm’s operational model or cost structure.
-90.09%
Negative 3Y OCF/share CAGR while INTC stands at 48.85%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-947.31%
Negative 10Y net income/share CAGR while INTC is at 3802.14%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-266.67%
Negative 5Y net income/share CAGR while INTC is 645.46%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-177.98%
Negative 3Y CAGR while INTC is 304.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1713.37%
10Y equity/share CAGR above 1.5x INTC's 65.90%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
91.55%
5Y equity/share CAGR above 1.5x INTC's 51.09%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.70%
3Y equity/share CAGR at 50-75% of INTC's 27.97%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
11.87%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.89%
Negative asset growth while INTC invests at 0.82%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.44%
We have a declining book value while INTC shows 4.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.51%
We’re deleveraging while INTC stands at 1.12%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.42%
Our R&D shrinks while INTC invests at 103.65%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
8.79%
SG&A declining or stable vs. INTC's 107.32%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.